Table 3.
Details of adverse drug reactions (ADRs)/adverse drug events (ADEs).
| CHN + WM | RDN + WM | TRQ + WM | XYP + WM | YHN + WM | WM | Total number of cases | |
|---|---|---|---|---|---|---|---|
| Gastrointestinal reaction | — | 1.09% (15/1379) |
0.71% (23/3227) |
1.60% (13/814) |
3.22% (21/653) |
1.61% (91/5651) |
163 |
| Rash itch | 0.47% (1/212) | 0.51% (7/1379) |
0.46% (15/3227) |
0.49% (4/814) |
0.61% (4/653) |
0.28% (16/5651) |
47 |
| Dizziness | — | 0.07% (1/1379) |
— | 1.84% (15/814) |
— | 0.28% (16/5651) |
32 |
| Antifeeding | — | 0.07% (1/1379) |
— | — | — | 0.11% (6/5651) |
7 |
| Increased breathe and heart rate | — | 0.07% (1/1379) |
— | — | — | — | 1 |
| Chill | — | 0.07% (1/1379) |
— | — | — | — | 1 |
| Dilute stool | — | 0.15% (2/1379) |
0.96% (31/3227) |
— | — | — | 33 |
| Cough aggravation | — | — | 0.06% (2/3227) |
— | — | — | 2 |
| Inciting | — | — | 0.15% (5/3227) |
— | — | — | 5 |
| Leukopenia | — | — | 0.19% (6/3227) |
— | — | 0.07% (4/5651) |
10 |
| Phlebitis | — | — | 0.06% (2/3227) |
— | — | 0.04% (2/5651) |
4 |
| Abnormal liver function | — | — | — | — | — | 0.02% (1/5651) |
1 |
| Not specifically described | — | 0.07% (1/1379) |
0.03% (1/3227) |
— | 0.15%(1/653) | 0.19% (11/5651) |
14 |
| Total | 0.47% (1/212) |
2.10% (29/1379) |
2.63% (85/3227) |
3.93%(32/814) | 3.98%(26/653) | 2.60% (147/5651) |
320 |